However, dual inhibition of CD24 and CD47, two molecules enhancing the “don’t eat me” signal, in combination with rituximab induced increased macrophage activity and promoted phagocytosis in MCL cells (42) (Figure 1). This evidence concerns the gene CD24 and mantle cell lymphoma.